Bateman, M., Wolf, A., Chimukangara, B., Brust, J. C. M., Lessells, R., Amico, R., . . . O'Donnell, M. R. (2022). Adherence Measured Using Electronic Dose Monitoring is Associated with Emergent Antiretroviral Resistance and Poor Outcomes in People with Human Immunodeficiency Virus/AIDS and Multidrug-Resistant Tuberculosis. Clinical infectious diseases, 75(9), 1489. https://doi.org/10.1093/cid/ciac232
Citace podle Chicago (17th ed.)Bateman, Mark, et al. "Adherence Measured Using Electronic Dose Monitoring Is Associated with Emergent Antiretroviral Resistance and Poor Outcomes in People with Human Immunodeficiency Virus/AIDS and Multidrug-Resistant Tuberculosis." Clinical Infectious Diseases 75, no. 9 (2022): 1489. https://doi.org/10.1093/cid/ciac232.
Citace podle MLA (9th ed.)Bateman, Mark, et al. "Adherence Measured Using Electronic Dose Monitoring Is Associated with Emergent Antiretroviral Resistance and Poor Outcomes in People with Human Immunodeficiency Virus/AIDS and Multidrug-Resistant Tuberculosis." Clinical Infectious Diseases, vol. 75, no. 9, 2022, p. 1489, https://doi.org/10.1093/cid/ciac232.